200,000+ products from a single source!

sales@angenechem.com

Home > Carboxes > 51-98-9

51-98-9

51-98-9 | 19-Norethindrone acetate

CAS No: 51-98-9 Catalog No: AG003DVW MDL No:MFCD00271615

Product Description

Catalog Number:
AG003DVW
Chemical Name:
19-Norethindrone acetate
CAS Number:
51-98-9
Molecular Formula:
C22H28O3
Molecular Weight:
340.4559
MDL Number:
MFCD00271615
IUPAC Name:
[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
InChI:
InChI=1S/C22H28O3/c1-4-22(25-14(2)23)12-10-20-19-7-5-15-13-16(24)6-8-17(15)18(19)9-11-21(20,22)3/h1,13,17-20H,5-12H2,2-3H3/t17-,18+,19+,20-,21-,22-/m0/s1
InChI Key:
IMONTRJLAWHYGT-ZCPXKWAGSA-N
SMILES:
C#C[C@@]1(CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CCC2=CC(=O)CC[C@H]12)OC(=O)C
EC Number:
200-132-0
UNII:
9S44LIC7OJ
NSC Number:
22844

Properties

Complexity:
695  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
6  
Defined Bond Stereocenter Count:
0
Exact Mass:
340.204g/mol
Formal Charge:
0
Heavy Atom Count:
25  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
340.463g/mol
Monoisotopic Mass:
340.204g/mol
Rotatable Bond Count:
3  
Topological Polar Surface Area:
43.4A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
3.5  

Literature

Title Journal
Several synthetic progestins disrupt the glial cell specific-brain aromatase expression in developing zebra fish. Toxicology and applied pharmacology 20160815
Utilization of human nuclear receptors as an early counter screen for off-target activity: a case study with a compendium of 615 known drugs. Toxicological sciences : an official journal of the Society of Toxicology 20150601
The progestin-only contraceptive medroxyprogesterone acetate, but not norethisterone acetate, enhances HIV-1 Vpr-mediated apoptosis in human CD4+ T cells through the glucocorticoid receptor. PloS one 20130101
Comparison of cervical mucus of 24/4 vs. 21/7 combined oral contraceptives. Contraception 20121201
Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ (Clinical research ed.) 20121009
A forgotten founding father of the Pill: Ferdinand Peeters, MD. The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception 20121001
Hormone therapy in postmenopausal women and risk of endometrial hyperplasia. The Cochrane database of systematic reviews 20120815
Primary fallopian tube carcinoma risk in users of postmenopausal hormone therapy in Finland. Gynecologic oncology 20120801
The hormonal profile of norethindrone acetate: rationale for add-back therapy with gonadotropin-releasing hormone agonists in women with endometriosis. Reproductive sciences (Thousand Oaks, Calif.) 20120601
Does hormone therapy, tibolone or raloxifene modify VEGF expression in cervical epithelial cells? Climacteric : the journal of the International Menopause Society 20120401
Use of norethindrone acetate alone for postoperative suppression of endometriosis symptoms. Journal of pediatric and adolescent gynecology 20120401
Interaction between oral estrogen plus progestogen therapy and ABO blood groups on coagulation activation in postmenopausal women. Menopause (New York, N.Y.) 20120301
Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment. Archives of gynecology and obstetrics 20120101
Novel insights into the vasoprotective role of heme oxygenase-1. International journal of hypertension 20120101
Hormone replacement therapy dependent changes in breast cancer-related gene expression in breast tissue of healthy postmenopausal women. Molecular oncology 20111201
Digitized assessment of mammographic breast density--effects of continuous combined hormone therapy, tibolone and black cohosh compared to placebo. Maturitas 20111201
Ionic liquid foam floatation coupled with solid phase extraction for separation and determination of hormones by high-performance liquid chromatography. Analytica chimica acta 20111017
Differential regulation of endogenous pro-inflammatory cytokine genes by medroxyprogesterone acetate and norethisterone acetate in cell lines of the female genital tract. Contraception 20111001
Application of multiwall carbon nanotubes-based matrix solid phase dispersion extraction for determination of hormones in butter by gas chromatography mass spectrometry. Journal of chromatography. A 20110805
Plasma leptin and adiponectin levels in hormone replacement therapy and contraception: effects of different progestogens. Fertility and sterility 20110701
Endometriosis presenting with hemorrhagic ascites. Archives of gynecology and obstetrics 20110601
Effects of different progestogens on human breast tumor cell growth. Climacteric : the journal of the International Menopause Society 20110601
Oral contraceptives and endometriosis. Human reproduction (Oxford, England) 20110601
Endometriosis, a modern syndrome. The Indian journal of medical research 20110601
Aromatase inhibitors in the treatment of bladder endometriosis. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20110501
Endometrial cancer associated with various forms of postmenopausal hormone therapy: a case control study. International journal of cancer 20110401
[Comparison of two different types of hormone therapy effects on haemostatic parameters in early postmenopausal women]. Srpski arhiv za celokupno lekarstvo 20110101
The emerging use of aromatase inhibitors for endometriosis treatment. Reproductive biology and endocrinology : RB&E 20110101
Letrozole and norethisterone acetate versus letrozole and triptorelin in the treatment of endometriosis related pain symptoms: a randomized controlled trial. Reproductive biology and endocrinology : RB&E 20110101
Use of aromatase inhibitors to treat endometriosis-related pain symptoms: a systematic review. Reproductive biology and endocrinology : RB&E 20110101
High-density real-time PCR-based in vivo toxicogenomic screen to predict organ-specific toxicity. International journal of molecular sciences 20110101
The effect of hormone therapy and tibolone on serum CD40L and ADAM-8 in healthy post-menopausal women. Journal of endocrinological investigation 20101101
Estrogen plus progestin treatment: effect of different progestin components on serum markers of apoptosis in healthy postmenopausal women. Fertility and sterility 20101101
The effect of dietary soy supplementation compared to estrogen and placebo on menopausal symptoms: a randomized controlled trial. Maturitas 20101101
Relative progestational and androgenic activity of four progestins used for male hormonal contraception assessed in vitro in relation to their ability to suppress LH secretion in the castrate male rat. Molecular and cellular endocrinology 20101026
Effects of combined hormone replacement therapy or its effective agents on the IGF-1 pathway in skeletal muscle. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 20101001
Genistein aglycone: a new therapeutic approach to reduce endometrial hyperplasia. Phytomedicine : international journal of phytotherapy and phytopharmacology 20100901
Effect of abrupt discontinuation versus gradual dose reduction of postmenopausal hormone therapy on hot flushes. Climacteric : the journal of the International Menopause Society 20100801
Hormone therapy affects plasma measures of factor VII-activating protease in younger postmenopausal women. Climacteric : the journal of the International Menopause Society 20100801
Updated clinical recommendations for the use of tibolone in Asian women. Climacteric : the journal of the International Menopause Society 20100801
Effects of continuous combined hormone replacement therapy and clodronate on bone mineral density in osteoporotic postmenopausal women: a 5-year follow-up. Maturitas 20100801
Membranous dysmenorrhea: a complication of treatment for endometriosis. Obstetrics and gynecology 20100801
Do the dose or route of administration of norethisterone acetate as a part of hormone therapy play a role in risk of breast cancer: national-wide case-control study from Finland. International journal of cancer 20100701
Synthesis and solid state characterization of molecular rotors with steroidal stators: ethisterone and norethisterone. Organic & biomolecular chemistry 20100628
Letrozole and norethisterone acetate in colorectal endometriosis. European journal of obstetrics, gynecology, and reproductive biology 20100601
Effects of hormone replacement therapy on glucose and lipid profiles and on cardiovascular risk parameters in postmenopausal women. Archives of gynecology and obstetrics 20100501
Effects of 17beta-oestradiol and norethisterone acetate on sulfonation and sialylation of gonadotrophins in post-menopausal women. Upsala journal of medical sciences 20100501
Short-term hormone treatment modulates emotion response circuitry in postmenopausal women. Fertility and sterility 20100401
Add-back therapy use and its impact on LA persistence in patients with endometriosis. Current medical research and opinion 20100301
Optimal tolerability of ultra-low-dose continuous combined 17beta-estradiol and norethisterone acetate: laboratory and safety results. Climacteric : the journal of the International Menopause Society 20100201
Norethisterone acetate in the treatment of colorectal endometriosis: a pilot study. Human reproduction (Oxford, England) 20100101
Dienogest: a new therapeutic agent for the treatment of endometriosis. Women's health (London, England) 20100101
Review of clinical experience with estradiol in combined oral contraceptives. Contraception 20100101
Hydrothermal endometrial ablation can reduce the need for hysterectomy and transfusion. JSLS : Journal of the Society of Laparoendoscopic Surgeons 20100101
Revisiting estrogen: efficacy and safety for postmenopausal bone health. Journal of osteoporosis 20100101
Progesterone, progestins, and the heart. Reviews in cardiovascular medicine 20100101
Letrozole combined with norethisterone acetate compared with norethisterone acetate alone in the treatment of pain symptoms caused by endometriosis. Human reproduction (Oxford, England) 20091201
Effects of menopausal hormone therapy on hemostatic parameters, blood pressure, and body weight: open-label comparison of randomized treatment with estradiol plus drospirenone versus estradiol plus norethisterone acetate. European journal of obstetrics, gynecology, and reproductive biology 20091201
Hormone replacement therapy and successful pregnancy in a patient with premature ovarian failure. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20091201
Endometrial cancer in postmenopausal women using estradiol-progestin therapy. Obstetrics and gynecology 20091201
Characteristics and recent evolution of menopausal hormone therapy use in a cohort of Swedish women. Climacteric : the journal of the International Menopause Society 20091001
Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS). Journal of cardiovascular translational research 20090901
Enhanced neuroactivation during verbal memory processing in postmenopausal women receiving short-term hormone therapy. Fertility and sterility 20090701
Progestins induce catalase activities in breast cancer cells through PRB isoform: correlation with cell growth inhibition. The Journal of steroid biochemistry and molecular biology 20090701
The decrease of soluble RAGE levels in rheumatoid arthritis patients following hormone replacement therapy is associated with increased bone mineral density and diminished bone/cartilage turnover: a randomized controlled trial. Rheumatology (Oxford, England) 20090701
Progestin may modify the effect of low-dose hormone therapy on mammographic breast density. Climacteric : the journal of the International Menopause Society 20090601
Postmenopausal hormone therapy with estradiol and norethisterone acetate and mammographic density: findings from a cross-sectional study among Norwegian women. Climacteric : the journal of the International Menopause Society 20090601
Association between efficacy and body weight or body mass index for two low-dose oral contraceptives. Contraception 20090601
Hormone therapy in postmenopausal women and risk of endometrial hyperplasia. The Cochrane database of systematic reviews 20090415
Validated UPLC method for the fast and sensitive determination of steroid residues in support of cleaning validation in formulation area. Journal of pharmaceutical and biomedical analysis 20090405
Improved bleeding profile and tolerability of tibolone versus transdermal E2/NETA treatment in postmenopausal women with female sexual dysfunction. Climacteric : the journal of the International Menopause Society 20090401
Effects of estrogens on oxidative protein damage in plasma and tissues in ovariectomised rats. Clinical and investigative medicine. Medecine clinique et experimentale 20090401
Parenteral administration of progestins for hormonal replacement therapy. The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception 20090401
Roles of estrogen and progesterone in endometrial hemodynamics and vascular endothelial growth factor production. Journal of the Chinese Medical Association : JCMA 20090401
A Canadian, multicentre study comparing the efficacy of a levonorgestrel-releasing intrauterine system to an oral contraceptive in women with idiopathic menorrhagia. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 20090401
Doping in sport--2. Quantification of the impurity 19-norandrostenedione in pharmaceutical preparations of norethisterone. Steroids 20090301
Follicular development in a 7-day versus 4-day hormone-free interval with an oral contraceptive containing 20 mcg ethinyl estradiol and 1 mg norethindrone acetate. Contraception 20090301
The effects of continuous combined oral estradiol and norethisterone on pulsatility index in internal carotid and uterine arteries in early postmenopausal Taiwanese women---a preliminary study. Taiwanese journal of obstetrics & gynecology 20090301
Hormone therapy modulates ET(A) mRNA expression in the aorta of ovariectomised New Zealand White rabbits. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20090301
Breast cancer risk in postmenopausal women using estradiol-progestogen therapy. Obstetrics and gynecology 20090101
Angeliq versus Activelle in normotensive postmenopausal women: a prospective, randomized pilot study. Menopause (New York, N.Y.) 20090101
Does hormone therapy improve age-related skin changes in postmenopausal women? A randomized, double-blind, double-dummy, placebo-controlled multicenter study assessing the effects of norethindrone acetate and ethinyl estradiol in the improvement of mild to moderate age-related skin changes in postmenopausal women. Journal of the American Academy of Dermatology 20080901
Central venous sinus thrombosis in a young woman taking norethindrone acetate for dysfunctional uterine bleeding: case report and review of literature. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 20080801
Differential impact of conventional-dose and low-dose postmenopausal hormone therapy, tibolone and raloxifene on C-reactive protein and other inflammatory markers. Journal of thrombosis and haemostasis : JTH 20080601
Rationale for low-dose systemic hormone replacement therapy and review of estradiol 0.5 mg/NETA 0.1 mg. Advances in therapy 20080601
The effects of estrogen therapy and estrogen combined with different androgenic progestins on carbohydrate and lipid metabolism in overweight-obese younger postmenopausal women. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20080601
Testosterone and gonadotropins but not estrogen associated with spatial ability in women suffering from schizophrenia: a double-blind, placebo-controlled study. Psychoneuroendocrinology 20080501
Differential impact of conventional and low-dose oral hormone therapy, tibolone and raloxifene on mammographic breast density, assessed by an automated quantitative method. BJOG : an international journal of obstetrics and gynaecology 20080501
Circulating levels of atherogenesis-associated adipocytokines and apoptotic markers are differentially influenced by hormone therapy, tibolone and raloxifene in healthy postmenopausal women. Climacteric : the journal of the International Menopause Society 20080401
Effects of estradiol and norethisterone on lipids, insulin resistance and carotid flow. Maturitas 20080320
Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in naturally menopausal women: results of a randomized active-controlled trial. The journal of sexual medicine 20080301
HT update: spotlight on estradiol/norethindrone acetate combination therapy. Clinical interventions in aging 20080301
Ultra-low-dose continuous combined estradiol and norethisterone acetate: improved bleeding profile in postmenopausal women. Climacteric : the journal of the International Menopause Society 20080201
Ultra low-dose hormone replacement therapy and bone protection in postmenopausal women. Maturitas 20080120
Circulating leptin and ghrelin are differentially influenced by estrogen/progestin therapy and raloxifene. Maturitas 20080120
Progestins oppose the effects of estradiol on the endothelin-1 receptor type B in coronary arteries from ovariectomized hyperlipidemic rabbits. Menopause (New York, N.Y.) 20080101
S100A4 overexpression proves to be independent marker for breast cancer progression. Cancer cell international 20080101
A comparison of hormone therapies on the urinary excretion of prostacyclin and thromboxane A2. Climacteric : the journal of the International Menopause Society 20080101
[Using pausogest for hormone replacement therapy--effect on plasma lipoproteins in menopause women]. Akusherstvo i ginekologiia 20080101
Transdermal hormone therapy in postmenopausal women: a review of metabolic effects and drug delivery technologies. Drug design, development and therapy 20080101
Tibolone and low-dose continuous combined hormone treatment: vaginal bleeding pattern, efficacy and tolerability. BJOG : an international journal of obstetrics and gynaecology 20071201
The influence of smoking on uterine bleeding during continuous and interrupted oral hormone therapy. Climacteric : the journal of the International Menopause Society 20071201
Management of sexual dysfunction in postmenopausal breast cancer patients taking adjuvant aromatase inhibitor therapy. Current oncology (Toronto, Ont.) 20071201
Clinical study investigating the role of lymphadenectomy, surgical castration and adjuvant hormonal treatment in endometrial stromal sarcoma. British journal of cancer 20071105
Effects of intranasal versus oral hormone therapy on asymmetric dimethylarginine in healthy postmenopausal women: a randomized study. Atherosclerosis 20071101
Effects of estrogen and estrogen-progestogen therapy on homocysteine levels and their correlation with carotid vascular resistance. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20071101
Progesterone induces apoptosis in TRAIL-resistant ovarian cancer cells by circumventing c-FLIPL overexpression. Journal of cellular biochemistry 20071001
The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women. Climacteric : the journal of the International Menopause Society 20071001
Bone density in adolescents treated with a GnRH agonist and add-back therapy for endometriosis. Journal of pediatric and adolescent gynecology 20071001
Effects of hormone treatment on hemostasis variables. Climacteric : the journal of the International Menopause Society 20071001
Letrozole and norethisterone acetate in rectovaginal endometriosis. Fertility and sterility 20070901
A one-year randomized double-blind, multicentre study to evaluate the effects of an oestrogen-reduced, continuous combined hormone replacement therapy preparation containing 1 mg oestradiol valerate and 2 mg dienogest on metabolism in postmenopausal women. The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception 20070901
Combined continuous ethinyl estradiol/norethindrone acetate does not improve forearm blood flow in postmenopausal women at risk for cardiovascular events: a pilot study. Journal of women's health (2002) 20070901
Age moderates the short-term effects of transdermal 17beta-estradiol on endothelium-dependent vascular function in postmenopausal women. Arteriosclerosis, thrombosis, and vascular biology 20070801
Effects on serum lipid and leptin levels of three different doses of norethisterone continuously combined with a fixed dose of 17beta-estradiol for nasal administration in postmenopausal women: a controlled, double-blind study. Fertility and sterility 20070801
Circulating chemoattractants RANTES, negatively related to endogenous androgens, and MCP-1 are differentially suppressed by hormone therapy and raloxifene. Atherosclerosis 20070701
Comparison of the effects of raloxifene and low-dose hormone replacement therapy on bone mineral density and bone turnover in the treatment of postmenopausal osteoporosis. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20070701
Formation of ethinyl estradiol in women during treatment with norethindrone acetate. The Journal of clinical endocrinology and metabolism 20070601
Neutral effect of ultra-low-dose continuous combined estradiol and norethisterone acetate on mammographic breast density. Climacteric : the journal of the International Menopause Society 20070601
Effects of standard and low dose 17beta-estradiol plus norethisterone acetate on body composition and leptin in postmenopausal women at risk of body mass index and waist girth related cardiovascular and metabolic disease. Saudi medical journal 20070601
Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system. Thrombosis and haemostasis 20070601
Preclinical and clinical properties of trimegestone: a potent and selective progestin. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20070601
Comparison of two forms of continuous combined hormone replacement therapy with respect to metabolic effects. Archives of gynecology and obstetrics 20070501
Effects of the components of hormone therapy on matrix metalloproteinases in breast-cancer cells: an in vitro study. Fertility and sterility 20070401
Hormonal therapy with patch or pill: how much does it matter? Thrombosis and haemostasis 20070401
Haemostatic activation in post-menopausal women taking low-dose hormone therapy: less effect with transdermal administration? Thrombosis and haemostasis 20070401
Ultra-low-dose estradiol and norethisterone acetate: effective menopausal symptom relief. Climacteric : the journal of the International Menopause Society 20070401
Testosterone addition during menopausal hormone therapy: effects on mammographic breast density. Climacteric : the journal of the International Menopause Society 20070401
Oral progestagens before menopause and breast cancer risk. British journal of cancer 20070312
Different types of postmenopausal hormone therapy and mammographic density in Norwegian women. International journal of cancer 20070215
Effects of raloxifene and continuous combined hormone therapy on haemostasis variables: a multicenter, randomized, double-blind study. Thrombosis research 20070101
Testosterone inhibits estrogen/progestogen-induced breast cell proliferation in postmenopausal women. Menopause (New York, N.Y.) 20070101
Differential effects of conventional and low dose oral hormone therapy (HT), tibolone, and raloxifene on coagulation and fibrinolysis. Thrombosis research 20070101
Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 micro g (Loestrin 24 Fe). Contraception 20070101
Monophasic estrogen-progestogen therapy and sexuality in postmenopausal women. Clinical drug investigation 20070101
Low-dose continuous combinations of hormone therapy and biochemical surrogate markers for vascular tone and inflammation: transdermal versus oral application. Menopause (New York, N.Y.) 20070101
Intratumoral hemorrhage of mammary phyllodes tumor after menstrual induction: a puzzling presentation. Tumori 20070101
Impact of combined estradiol and norethindrone therapy on visuospatial working memory assessed by functional magnetic resonance imaging. The Journal of clinical endocrinology and metabolism 20061101
Conventional-dose hormone therapy (HT) and tibolone, but not low-dose HT and raloxifene, increase markers of activated coagulation. Maturitas 20061020
Endometrial safety, overall safety and tolerability of transdermal continuous combined hormone replacement therapy over 96 weeks: a randomized open-label study. Climacteric : the journal of the International Menopause Society 20061001
Effects of estradiol alone and combined with norethisterone acetate on pulse-wave velocity in hypertensive postmenopausal women. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20061001
Randomized trial of effects of continuous combined HRT on markers of lipids and coagulation in women with acute coronary syndromes: WHISP Pilot Study. European heart journal 20060901
Beneficial effect of tibolone on mood, cognition, well-being, and sexuality in menopausal women. Neuropsychiatric disease and treatment 20060901
Tibolone and estradiol plus norethisterone acetate similarly influence endothelium-dependent vasodilatation in healthy postmenopausal women. Fertility and sterility 20060801
Does the hormonal situation modify lipid effects by lifestyle factors in middle-aged women? Results from a population-based study of Swedish women: the women's health in the Lund area study. Metabolism: clinical and experimental 20060801
Effects of oral continuous 17beta-estradiol plus norethisterone acetate replacement therapy on abdominal subcutaneous fat, serum leptin levels and body composition. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20060701
No increase in C-reactive protein levels during intranasal compared to oral hormone therapy in healthy post-menopausal women. Human reproduction (Oxford, England) 20060601
Effects of low-dose norethindrone acetate plus ethinyl estradiol (0.5 mg/2.5 microg) in women with postmenopausal symptoms: updated analysis of three randomized, controlled trials. Clinical therapeutics 20060601
Osteoporosis in primary biliary cirrhosis: a randomized trial of the efficacy and feasibility of estrogen/progestin. Digestive diseases and sciences 20060601
Which progestogen is more likely to increase the risk of fatal myocardial infarction: a combination of epidemiological and trial evidence. Maturitas 20060520
Combined hormone replacement therapy improves lipids but may increase leucocytes. Journal of internal medicine 20060501
The effect of low dose hormone therapy on mammographic breast density. Maturitas 20060420
The effect of oestradiol and neta on immunohistochemical staining of iNOS and eNOS in coronary arteries of ovariectomized rats. Histology and histopathology 20060401
Differential effect of hormone therapy and tibolone on lipids, lipoproteins, and the atherogenic index of plasma. Journal of cardiovascular pharmacology 20060401
A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness. Maturitas 20060320
The effect of continuous combined HRT on glucose homeostasis and plasma lipids. A placebo-controlled study in postmenopausal women with type 2 diabetes. Maturitas 20060320
Effects of alendronate and hormone replacement therapy, alone and in combination, on saliva, periodontal conditions and gingival crevicular fluid matrix metalloproteinase-8 levels in women with osteoporosis. Oral diseases 20060301
Effects of four different regimens of hormone replacement therapy on hemostatic parameters: a prospective randomized study. Maturitas 20060220
Effects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleeding. Archives of gynecology and obstetrics 20060201
[Pregnancies occurring during oral contraception: lessons from the GRECO study]. Gynecologie, obstetrique & fertilite 20060201
Comparison of effects of pravastatin and hormone therapy on soluble P-selectin and platelet P-selectin expression in postmenopausal hypercholesterolemic women. Maturitas 20060120
Prevention of postmenopausal bone loss with long-cycle hormone replacement therapy. Maturitas 20060120
Evaluation of mammographic density and (99m)Tc-sestamibi scintimammographic uptake in postmenopausal women on hormone replacement therapy. Maturitas 20060110
A comparison of effects of sequential transdermal administration versus oral administration of estradiol plus norethisterone acetate on serum NO levels in postmenopausal women. Maturitas 20060110
Hormone replacement therapy and mortality in 52- to 70-year-old women: the Kuopio Osteoporosis Risk Factor and Prevention Study. European journal of endocrinology 20060101
The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women. Menopause (New York, N.Y.) 20060101
Effects of intranasal 17beta-estradiol administration on serum bioactive interleukin-6 and C-reactive protein levels in healthy postmenopausal women. Menopause (New York, N.Y.) 20060101
Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri- and postmenopausal women: impact on depression, vasomotor symptoms, sleep, and quality of life. Menopause (New York, N.Y.) 20060101
Different effects of tibolone and low-dose EPT in the management of postmenopausal women with primary headaches. Menopause (New York, N.Y.) 20060101
[Influence of hormone replacement therapy in postmenopausal women with type 2 diabetes and hyperlipidemia on lipid and glucose metabolism]. Srpski arhiv za celokupno lekarstvo 20060101
Treatment of symptomatic rectovaginal endometriosis with an estrogen-progestogen combination versus low-dose norethindrone acetate. Fertility and sterility 20051101
Synthetic progestins used in HRT have different glucocorticoid agonist properties. Molecular and cellular endocrinology 20051020
The effect of hormone replacement therapy and/or exercise on skeletal muscle attenuation in postmenopausal women: a yearlong intervention. Clinical physiology and functional imaging 20050901
Bleeding profile and endometrial safety of continuous combined regimens 1 mg 17beta-estradiol/trimegestone versus 1 or 2 mg 17beta-estradiol/norethisterone acetate in postmenopausal women. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20050901
Apoptosis and proliferation in breast cancer cells, cultured in vitro: effects of SERMs. Climacteric : the journal of the International Menopause Society 20050901
A comparison of two progestins on myocardial ischemia-reperfusion injury in ovariectomized monkeys receiving estrogen therapy. Coronary artery disease 20050801
Effect of different preparations of hormone therapy on lipid and glucose metabolism, coagulation factors, and bone mineral density in overweight and obese postmenopausal women. Fertility and sterility 20050801
Efficacy on climacteric symptoms of a continuous combined regimen of 1 mg 17beta-estradiol and trimegestone versus two regimens combining 1 or 2 mg 17beta-estradiol and norethisterone acetate. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20050801
A study of the control of climacteric symptoms in postmenopausal women following sequential regimens of 1 mg 17beta-estradiol and trimegestone compared with a regimen containing 1 mg estradiol valerate and norethisterone over a two-year period. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20050801
A comparative 2-year study of the effects of sequential regimens of 1 mg 17beta-estradiol and trimegestone with a regimen containing estradiol valerate and norethisterone on the bleeding profile and endometrial safety in postmenopausal women. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20050801
An overview of menopausal oestrogen-progestin hormone therapy and breast cancer risk. British journal of cancer 20050606
The effect of the phytoestrogen genistein and hormone replacement therapy on homocysteine and C-reactive protein level in postmenopausal women. Acta obstetricia et gynecologica Scandinavica 20050501
The effects of hormone replacement on the biomechanical properties of the uterosacral and round ligaments in the monkey model. American journal of obstetrics and gynecology 20050501
Gonadal protection by a gonadotropin-releasing hormone agonist depot in young women with Hodgkin's disease undergoing chemotherapy. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20050501
Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene. Maturitas 20050411
Lipids and clotting factors during low dose transdermal estradiol/norethisterone use. Maturitas 20050411
The impact of a monophasic continuous estro-progestogenic treatment on Latin American menopausal women. Maturitas 20050314
Oral contraceptives as substrates and inhibitors for human cytosolic SULTs. Journal of biochemistry 20050301
Differential effects of estrogens and progestins on the anticoagulant tissue factor pathway inhibitor in the rat. The Journal of steroid biochemistry and molecular biology 20050301
Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20050301
Influence of different HRT regimens on mammographic density. Maturitas 20050214
Different effects of tibolone and continuous combined estrogen plus progestogen hormone therapy on sex hormone binding globulin and free testosterone levels--an association with mammographic density. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20050201
The effect of hormone replacement therapy on oxidized low density lipoprotein levels and paraoxonase activity in postmenopausal women. The Tohoku journal of experimental medicine 20050101
Validation of the Women's Health Initiative Insomnia Rating Scale in a multicenter controlled clinical trial. Psychosomatic medicine 20050101
Hormone replacement therapy does not affect the 24-hour heart rate variability in postmenopausal women: results of a randomized, placebo-controlled trial with two regimens. Pacing and clinical electrophysiology : PACE 20050101
Dose effects of progesterone in add-back therapy during GnRHa treatment. The Journal of reproductive medicine 20050101
A multicenter, open-label study to evaluate satisfaction and menopausal quality of life in women using transdermal estradiol/norethindrone acetate therapy for the management of menopausal signs and symptoms. Gynecologic and obstetric investigation 20050101
Evaluation of the effects of various gestagens on insulin sensitivity, using homeostatic model assessment, in postmenopausal women on hormone replacement therapy. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20050101
Hormone use and patient concerns after the findings of the Women's Health Initiative. Menopause (New York, N.Y.) 20050101
Interleukin-6 and flow-mediated dilatation as markers of increased vascular inflammation in women receiving hormone therapy. Menopause (New York, N.Y.) 20050101
Oral hormone therapy with 17beta-estradiol and 17beta-estradiol in combination with norethindrone acetate in the prevention of bone loss in early postmenopausal women: dose-dependent effects. Menopause (New York, N.Y.) 20050101
Progestins used in hormonal replacement therapy display different effects in coronary arteries from New Zealand white rabbits. Maturitas 20041210
Progesterone abolishes estrogen and/or atorvastatin endothelium dependent vasodilatory effects. Atherosclerosis 20041101
Apoptosis, proliferation, and sex steroid receptors in postmenopausal endometrium before and during HRT. Maturitas 20041015
Effect of hormone therapy and raloxifene on serum VE-cadherin in postmenopausal women. Fertility and sterility 20040901
Randomized trial of effects of estradiol in combination with either norethisterone acetate or trimegestone on lipids and lipoproteins in postmenopausal women. Climacteric : the journal of the International Menopause Society 20040901
Anticardiolipin antibodies during hormone replacement therapy in healthy postmenopausal women. Maturitas 20040820
A comparison of the central effects of different progestins used in hormone replacement therapy. Maturitas 20040820
Carotid and uterine vascular resistance in short-term hormone replacement therapy postmenopausal users. Maturitas 20040820
Effects of continuous combined conjugated estrogen/medroxyprogesterone acetate and 17beta-estadiol/norethisterone acetate on lipids and lipoproteins. Maturitas 20040615
Mammographic breast density, hormones, and growth factors during continuous combined hormone therapy. Fertility and sterility 20040601
Effect of previous hormone replacement therapy on endometrial polyps during menopause. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20040601
Long-term effects of two different continuous combined regimens of hormone replacement therapy on well-being. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20040601
Uterine effects of estrogen plus progestin therapy and raloxifene: adjudicated results from the EURALOX study. Obstetrics and gynecology 20040501
Effect of hormone replacement therapy, tibolone and raloxifene on serum lipids, apolipoprotein A1, apolipoprotein B and lipoprotein(a) in Greek postmenopausal women. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20040501
Randomized trial of effect of transdermal continuous combined hormone replacement therapy on cardiovascular risk markers. British journal of haematology 20040301
Determination of the physical state of norethindrone acetate containing transdermal drug delivery systems by isothermal microcalorimetry, X-ray diffraction, and optical microscopy. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20040301
Use of isothermal heat conduction microcalorimetry, X-ray diffraction, and optical microscopy for characterisation of crystals grown in steroid combination-containing transdermal drug delivery systems. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20040301
Endogenous estradiol metabolism during treatment with oral contraceptives. International journal of clinical pharmacology and therapeutics 20040301
Different cerebrovascular effects of medroxyprogesterone acetate and norethisterone acetate in the New Zealand White rabbit. Climacteric : the journal of the International Menopause Society 20040301
Endometrial safety and tolerability of triphasic sequential hormone replacement estradiol valerate/medroxyprogesterone acetate therapy regimen. Climacteric : the journal of the International Menopause Society 20040301
A comparative study of breast cell proliferation during hormone replacement therapy: effects of tibolon and continuous combined estrogen-progestogen treatment. Climacteric : the journal of the International Menopause Society 20040301
A low-dose start in hormone replacement therapy provides a beneficial bleeding profile and few side-effects: randomized comparison with a conventional-dose regimen. Climacteric : the journal of the International Menopause Society 20040301
Low-dose oral combination of 17beta-estradiol and norethisterone acetate in postmenopausal women decreases factor VII, fibrinogen, antithrombin and plasminogen activator inhibitor-1. Climacteric : the journal of the International Menopause Society 20040301
Well-being at onset of hormone replacement therapy: comparison between two continuous combined regimens. Climacteric : the journal of the International Menopause Society 20040301
The effect of hormone replacement therapy on endothelial function in postmenopausal women with hypertension. Medical science monitor : international medical journal of experimental and clinical research 20040201
Effects of alendronate and hormone replacement therapy, alone and in combination, on bone mass and markers of bone turnover in elderly women with osteoporosis. The Journal of clinical endocrinology and metabolism 20040201
Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study. Fertility and sterility 20040201
Effect of hormone replacement therapy on cardiovascular risk factors in postmenopausal women with diabetes. Diabetes, obesity & metabolism 20040101
Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin system in early postmenopausal women. The Journal of clinical endocrinology and metabolism 20040101
Effect on endometrium of combined oestrogen-progestogen replacement therapy of 1 mg 17beta-estradiol and 0.5 mg norethisterone acetate. Clinical and experimental obstetrics & gynecology 20040101
Risk of progression in complex and atypical endometrial hyperplasia: clinicopathologic analysis in cases with and without progestogen treatment. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20040101
The effect of hormone therapy and raloxifene on serum matrix metalloproteinase-2 and -9 in postmenopausal women. Menopause (New York, N.Y.) 20040101
A cost-effectiveness evaluation of two continuous-combined hormone therapies for the management of moderate-to-severe vasomotor symptoms. Menopause (New York, N.Y.) 20040101
Estrogen replacement therapy in combination with continuous intrauterine progestin administration reduces the amount of circulating oxidized LDL in postmenopausal women: dependence on the dose of progestin. Annals of medicine 20040101
Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and placebo-controlled study. Menopause (New York, N.Y.) 20040101
Measurement of aortic blood flow by magnetic resonance below and above the origin of the coronary arteries in postmenopausal hormone replacement therapy. Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance 20040101
Combined hormone therapy in postmenopausal women with features of metabolic syndrome. Results from a population-based study of Swedish women: Women's Health in the Lund Area study. Menopause (New York, N.Y.) 20040101
Anogenital distance in human male and female newborns: a descriptive, cross-sectional study. Environmental health : a global access science source 20040101
Hormone replacement therapy, calcium and vitamin D3 versus calcium and vitamin D3 alone decreases markers of cartilage and bone metabolism in rheumatoid arthritis: a randomized controlled trial [ISRCTN46523456]. Arthritis research & therapy 20040101
Changes in bone density and turnover after alendronate or estrogen withdrawal. Menopause (New York, N.Y.) 20040101
[The effect of transdermal hormone replacement therapy on vasomotor symptoms in perimenopausal women]. Wiadomosci lekarskie (Warsaw, Poland : 1960) 20040101
Hormone replacement therapy, C-reactive protein, and fibrinogen in healthy postmenopausal women. Maturitas 20031210
Effect of hormone replacement therapy on serum levels of tumor markers in healthy postmenopausal women. Maturitas 20031210
Differential effects of progestogens on breast cancer cell lines. Maturitas 20031210
Effects of low-dose 17-beta-estradiol plus norethisterone acetate and tibolone on fasting plasma homocysteine levels in postmenopausal women. Acta obstetricia et gynecologica Scandinavica 20031201
Impact of different progestins on endometrial vascularisation of postmenopausal women. A retrospective image analysis-morphometric study. Maturitas 20031120
The effects of hormone replacement therapy type on pulmonary functions in postmenopausal women. Maturitas 20031120
An overview of nomegestrol acetate selective receptor binding and lack of estrogenic action on hormone-dependent cancer cells. The Journal of steroid biochemistry and molecular biology 20031101
Effects of progestins of human proliferative endometrium: an in vitro model of potential clinical relevance. International journal of molecular medicine 20031001
The lipid and clinical effects of sequential transdermal estradiol and estradiol/norethisterone acetate in 674 women. Archives of gynecology and obstetrics 20031001
Increased risk of stroke in hypertensive women using hormone therapy: analyses based on the Danish Nurse Study. Archives of neurology 20031001
Continuous intrauterine compared with cyclic oral progestin administration in perimenopausal HRT. Maturitas 20030925
Positive impact of hormone replacement therapy on the fibrinolytic system: a long-term randomized controlled study in healthy postmenopausal women. Journal of thrombosis and haemostasis : JTH 20030901
Effects of hormone therapy and alendronate on C-reactive protein, E-selectin, and sex hormone-binding globulin in osteoporotic women. Fertility and sterility 20030901
[Changes in bone density in hemodialysed women treated with transdermal hormone replacement therapy]. Ginekologia polska 20030901
Modification of serum IGF-I, IGFBPs and SHBG levels by different HRT regimens. Maturitas 20030820
Changes in body composition during post-menopausal hormone therapy: a 2 year prospective study. Human reproduction (Oxford, England) 20030801
Clinical efficacy and safety of combined estradiol valerate and dienogest: a new no-bleed treatment. Climacteric : the journal of the International Menopause Society 20030801
Hormone replacement therapy and risk of breast cancer: the role of progestins. Acta obstetricia et gynecologica Scandinavica 20030701
The effect of various regimens of hormone replacement therapy on mammographic breast density. Maturitas 20030630
Influence of silicone elastomer solubility and diffusivity on the in vitro release of drugs from intravaginal rings. Journal of controlled release : official journal of the Controlled Release Society 20030624
Effect of hormone replacement therapy on bone quality in early postmenopausal women. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20030601
Serum lipids and apolipoproteins in Greek postmenopausal women: association with estrogen, estrogen-progestin, tibolone and raloxifene therapy. Journal of endocrinological investigation 20030601
Contrasting effects of two hormone replacement therapies on the cardiovascular and mammary gland outcomes in surgically postmenopausal monkeys. American journal of obstetrics and gynecology 20030501
Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003. Climacteric : the journal of the International Menopause Society 20030501
Bioassay of steroid hormone agonist and antagonist activities of anti-androgens on mammary gland, seminal vesicles and spleen of male mice. Journal of veterinary medicine. A, Physiology, pathology, clinical medicine 20030501
Effect of genistein on endothelial function in postmenopausal women: a randomized, double-blind, controlled study. The American journal of medicine 20030415
Low-dose hormone therapy and carbohydrate metabolism. Fertility and sterility 20030301
Effects of low-dose, continuous combined estradiol and noretisterone acetate on menopausal quality of life in early postmenopausal women. Maturitas 20030225
A randomized, double-blind, placebo-controlled, multicenter study that assessed the endometrial effects of norethindrone acetate plus ethinyl estradiol versus ethinyl estradiol alone. American journal of obstetrics and gynecology 20030201
A multicentre randomised trial to compare uterine safety of raloxifene with a continuous combined hormone replacement therapy containing oestradiol and norethisterone acetate. BJOG : an international journal of obstetrics and gynaecology 20030201
The effects of hormonal therapy on aortic stiffness and left ventricular diastolic function. Acta cardiologica 20030201
Effects of the natural and artificial menstrual cycle on the production of osteoprotegerin and the bone resorptive cytokines IL-1beta and IL-6. Calcified tissue international 20030101
Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy. American journal of obstetrics and gynecology 20030101
Can we decrease breakthrough bleeding in patients with endometriosis on norethindrone acetate? International journal of fertility and women's medicine 20030101
Effect of low-dose transdermal E2/NETA on the reduction of postmenopausal bone loss in women. Menopause (New York, N.Y.) 20030101
Hormone replacement therapy in rheumatoid arthritis is associated with lower serum levels of soluble IL-6 receptor and higher insulin-like growth factor 1. Arthritis research & therapy 20030101
The short-term effects of different regimens of hormone replacement therapy on left ventricular structure and performance in healthy postmenopausal women. A prospective, controlled echocardiographic study. Gynecologic and obstetric investigation 20030101
Bleeding patterns in peri and postmenopausal women taking a continuous combined regimen of estradiol with norethisterone acetate or a conventional sequential regimen of conjugated equine estrogens with medrogestone. Maturitas 20021210
Wnt-7a is upregulated by norethisterone in human endometrial epithelial cells: a possible mechanism by which progestogens reduce the risk of estrogen-induced endometrial neoplasia. Cancer letters 20021201
Effects of different progestin regimens in hormone replacement therapy on blood coagulation factor VII and tissue factor pathway inhibitor. Human reproduction (Oxford, England) 20021201
A randomized, placebo-controlled trial of the effects of continuous combined hormone replacement therapy on coagulation and fibrinolytic systems in healthy postmenopausal women. Fertility and sterility 20021201
Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women. Climacteric : the journal of the International Menopause Society 20021201
Impact of hormone replacement therapy on endogenous estradiol metabolism in postmenopausal women. Maturitas 20021025
Haemostatic risk factors in healthy postmenopausal women taking hormone replacement therapy. Maturitas 20021025
Effects of tibolone and combined 17beta-estradiol and norethisterone acetate on serum C-reactive protein in healthy post-menopausal women: a randomized trial. Human reproduction (Oxford, England) 20021001
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20021001
Norethisterone acetate in combination with estrogen: effects on the skeleton and other organs. A review. American journal of obstetrics and gynecology 20021001
Effects of low dose hormone replacement therapy on markers of inflammation in postmenopausal women. Maturitas 20020930
[Tibolone]. Presse medicale (Paris, France : 1983) 20020907
A dynamic mechanical method for determining the silicone elastomer solubility of drugs and pharmaceutical excipients in silicone intravaginal drug delivery rings. Biomaterials 20020901
Lipids and antioxidative effects of estradiol and sequential norethisterone acetate treatment in a 3-month randomized controlled trial. Climacteric : the journal of the International Menopause Society 20020901
National differences in lipid response to postmenopausal hormone replacement therapy. Maturitas 20020830
The values of urinary NTx in postmenopausal women undergoing HRT; the role of additional alendronate therapy. Maturitas 20020830
Lack of stimulatory effect of dienogest on the expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 by endothelial cell as compared with other synthetic progestins. Maturitas 20020830
Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy: follow up study. BMJ (Clinical research ed.) 20020803
Effects of oral continuous and transdermal cyclic 17-beta estradiol and norethindrone acetate replacement therapy on platelet aggregation in postmenopausal women. The Journal of reproductive medicine 20020801
Cyclic estrogen-progestin hormone therapy as a new therapeutic approach in the treatment of functional alterations of the hypothalamus-pituitary-ovary axis: case reports. Endocrine research 20020801
Impact of different hormone replacement therapy regimens on the size of myoma uteri in postmenopausal period: tibolone versus transdermal hormonal replacement system. Maturitas 20020725
Change in bone mass distribution induced by hormone replacement therapy and high-impact physical exercise in post-menopausal women. Bone 20020701
Effect of long-term hormone replacement therapy on plasma homocysteine in postmenopausal women: a randomized controlled study. American journal of obstetrics and gynecology 20020701
Intermittent progestin administration as part of hormone replacement therapy: long-term comparison between estradiol 1 mg combined with intermittent norgestimate and estradiol 2 mg combined with constant norethisterone acetate. Acta obstetricia et gynecologica Scandinavica 20020701
[Amenorrhea rate after switch from sequential hormone replacement therapy to continuous combined administration of low dose estradiol and norethisterone acetate]. Zentralblatt fur Gynakologie 20020701
Effects of a lipid lowering fibrate and hormone replacement therapy on serum lipids and lipoproteins in overweight postmenopausal women with elevated triglycerides. Maturitas 20020520
Transvaginal sonographic monitoring of the uterine effects of raloxifene and a continuous combined replacement therapy in postmenopausal women. Maturitas 20020520
Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up. Obstetrics and gynecology 20020501
Hormone replacement therapy: estrogen and progestin effects on plasma C-reactive protein concentrations. American journal of obstetrics and gynecology 20020501
Effect of raloxifene on the ovarian circulation in women after menopause. American journal of obstetrics and gynecology 20020501
Positive effects on cardiovascular and breast metabolic markers of oral estradiol and dydrogesterone in comparison with transdermal estradiol and norethisterone acetate. Maturitas 20020425
Number of years since menopause: spontaneous bone loss is dependent but response to hormone replacement therapy is independent. Bone 20020401
Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density. American journal of obstetrics and gynecology 20020401
Norethindrone acetate (NA) and ethinyl estradiol (EE) related oxidative transformation products in stability samples of formulated drug product: synthesis of authentic references. Steroids 20020301
Randomized, double-masked, 2-year comparison of tibolone with 17beta-estradiol and norethindrone acetate in preventing postmenopausal bone loss. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20020301
The efficacy of two dosages of a continuous combined hormone replacement regimen. Maturitas 20020226
Effects of estrogen-progestin and raloxifene therapy on nitric oxide, prostacyclin and endothelin-1 synthesis. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20020201
Does postmenopausal hormone replacement therapy affect cardiac autonomic regulation in osteoporotic women? Menopause (New York, N.Y.) 20020101
Estradiol valerate/dienogest. Drugs 20020101
Low dose transdermal estradiol/norethisterone acetate treatment over 2 years does not cause endometrial proliferation in postmenopausal women. Menopause (New York, N.Y.) 20020101
Insulin resistance and lipids in hypertensive women on hormone replacement therapy. Blood pressure 20020101
Effects of sequential combined transdermal and oral hormone replacement therapies on serum lipid and lipoproteins in postmenopausal women. Archives of gynecology and obstetrics 20020101
Tibolone versus 17beta-estradiol/norethisterone: effects on the proliferation of human breast cancer cells. European journal of gynaecological oncology 20020101
Changes in lipid and lipoprotein profile in postmenopausal women receiving low-dose combinations of 17beta-estradiol and norethisterone acetate. Menopause (New York, N.Y.) 20020101
Sensitivity and specificity of bioassay of estrogenicity on mammary gland and uterus of female mice. Physiological research 20020101
Effect of long-term continuous combined hormone replacement therapy with estradiol valerate and either dienogest or norethisterone acetate on mammographic density in postmenopausal women. Medscape women's health 20020101
Effects of long-term oral hormone replacement therapy on plasma nitric oxide and beta-endorphin levels in postmenopausal women. Gynecologic and obstetric investigation 20020101
Spotlight on estradiol and norgestimate as hormone replacement therapy in postmenopausal women. Treatments in endocrinology 20020101
Continuous combined replacement therapy in postmenopausal women: effect on plasma lipoproteins, bone mass and the endometrium. Hormones (Athens, Greece) 20020101
Effective bleeding control and symptom relief by lower dose regimens of continuous combined hormone replacement therapy: a randomized comparative dose-ranging study. Maturitas 20011214
Contraceptive vaginal rings. Seminars in reproductive medicine 20011201
The effect of continuous combined hormone replacement therapy on arterial reactivity in postmenopausal women with established angina pectoris. Atherosclerosis 20011201
The effects of postmenopausal hormone replacement therapy and oral contraceptives on the endogenous estradiol metabolism. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20011201
Differential effects of raloxifene and continuous combined hormone replacement therapy on biochemical markers of cardiovascular risk: results from the Euralox 1 study. Climacteric : the journal of the International Menopause Society 20011201
Acceptability and patterns of endometrial bleeding in estradiol-based HRT regimens: a comparative study of cyclical sequential combinations of trimegestone or norethisterone acetate. Climacteric : the journal of the International Menopause Society 20011201
Combined hormone replacement therapy improves endothelial function in healthy postmenopausal women. Journal of internal medicine 20011201
Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double-blind, placebo-controlled trial. British journal of haematology 20011101
Effects of oral and transdermal hormone replacement therapy on internal carotid artery pulsatility indices in postmenopausal women. A prospective, randomized, comparative study. The Journal of reproductive medicine 20011101
Effect of norethindrone acetate on hormone levels and markers of bone turnover in estrogen-treated postmenopausal women. Endocrine research 20011101
Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy. Obesity research 20011001
Anti-ischemic action of estrogen-progestogen continuous combined hormone replacement therapy in postmenopausal women with established angina pectoris: a randomized, placebo-controlled, double-blind, parallel-group trial. Journal of cardiovascular pharmacology 20010901
Mammographic density changes during different postmenopausal hormone replacement therapies. Fertility and sterility 20010901
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma no concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women. Arteriosclerosis, thrombosis, and vascular biology 20010901
Estimation of hormone replacement therapy influence on serum galanin level in postmenopausal women. Climacteric : the journal of the International Menopause Society 20010901
Trimegestone: expanding therapeutic choices for the treatment of the menopause. Expert opinion on investigational drugs 20010901
Comparison between 1 year oral and transdermal oestradiol and sequential norethisterone acetate on circulating concentrations of leptin in postmenopausal women. Human reproduction (Oxford, England) 20010801
Pharmacology and toxicology of ethinyl estradiol and norethindrone acetate in experimental animals. Regulatory toxicology and pharmacology : RTP 20010801
Sensitivity to a neurosteroid is increased during addition of progestagen to postmenopausal hormone replacement therapy. Neuroendocrinology 20010601
Bleeding patterns in postmenopausal women using continuous combination hormone replacement therapy with conjugated estrogen and medroxyprogesterone acetate or with 17beta-estradiol and norethindrone acetate. American journal of obstetrics and gynecology 20010501
The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism--results from a randomized, double-blind, clinical trial. Thrombosis and haemostasis 20010501
Constant estrogen, intermittent progestogen vs. continuous combined hormone replacement therapy: tolerability and effect on vasomotor symptoms. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20010301
Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy. Fertility and sterility 20010301
Efficacy of levormeloxifene in the prevention of postmenopausal bone loss and on the lipid profile compared to low dose hormone replacement therapy. The Journal of clinical endocrinology and metabolism 20010201
The insulin-like growth factor-I system and hormone replacement therapy. Fertility and sterility 20010201
Allergic contact dermatitis from estradiol and norethisterone acetate in a transdermal hormonal patch. Contact dermatitis 20010201
Minimal androgenic activity of a new oral contraceptive containing norethindrone acetate and graduated doses of ethinyl estradiol. Contraception 20010201
Charcoal treatment and risk of escape ovulation in oral contraceptive users. Human reproduction (Oxford, England) 20010101
Temporal changes in cardiac function and cerebral blood flow during sequential postmenopausal hormone replacement. American journal of obstetrics and gynecology 20010101
The effects of sequential combined oral 17beta-estradiol norethisterone acetate on insulin sensitivity and body composition in healthy postmenopausal women: a randomized single blind placebo-controlled study. Menopause (New York, N.Y.) 20010101
Hormone replacement therapy after invasive ovarian serous cystadenocarcinoma treatment: the effect on survival. Menopause (New York, N.Y.) 20010101
Bioequivalence and relative bioavailability of three estradiol and norethisterone acetate-containing hormone replacement therapy tablets. International journal of clinical pharmacology and therapeutics 20010101
The possible role of enterohepatic cycling on bioavailability of norethisterone and gestodene in women using combined oral contraceptives. Contraception 20010101
The metabolic and bone density effects of continuous combined 17-beta estradiol and noresthisterone acetate treatments in Thai postmenopausal women: a double-blind placebo-controlled trial. Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20010101
Continuous combined hormone replacement therapy with oral 17beta-estradiol and norethisterone acetate improves homocysteine metabolism in postmenopausal women. Menopause (New York, N.Y.) 20010101
Unscheduled bleeding during initiation of continuous combined hormone replacement therapy: a direct comparison of two combinations of norethindrone acetate and ethinyl estradiol to medroxyprogesterone acetate and conjugated equine estrogens. Menopause (New York, N.Y.) 20010101
Bone-resorbing cytokines from peripheral blood mononuclear cells after hormone replacement therapy: a longitudinal study. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20010101
Hormone replacement therapy and prevention of vertebral fractures: a meta-analysis of randomised trials. BMC musculoskeletal disorders 20010101
Estradiol and norgestimate: a review of their combined use as hormone replacement therapy in postmenopausal women. Drugs & aging 20010101
[A clinical assessment of a 3 month replacement therapy effectiveness with low norethisterone acetate (Activelle) in postmenopausal women]. Przeglad lekarski 20010101
Endometrial cancer after combined hormone replacement therapy. Maturitas 19990315
Effect of different insertion regimens on side effects with a combination contraceptive vaginal ring. Contraception 19971001
Alcohol ingestion enhances hepatocarcinogenesis induced by synthetic estrogen and progestin in the rat. Cancer detection and prevention 19940101
The new pills: awaiting the next generation of oral contraceptives. Family planning perspectives 19920101
Effect of alcohol ingestion on carcinogenesis by synthetic estrogen and progestin in the rat liver. Japanese journal of cancer research : Gann 19910701
[Primary adenoma of the liver with spontaneous rupture following long-term intake of gestagens. Case report]. Der Internist 19830501
[Occurrence and histological structure of adenocarcinoma of the endocervix after long-term use of oral contraceptives (author's transl)]. Geburtshilfe und Frauenheilkunde 19820401
Progestogens and arterial disease--evidence from the Royal College of General Practitioners' study. American journal of obstetrics and gynecology 19820315
Progestogen effects and their relationship to lipoprotein changes. A report from the Oral Contraception Study of the Royal College of General Practitioners. Acta obstetricia et gynecologica Scandinavica. Supplement 19820101
Oral contraception and thromboembolism: the role of progestogens. The New Zealand medical journal 19800813
Studies of the components of an oral contraceptive agent in albino rats. II. Progestogenic component and comparison of effects of the components and the combined agent. Journal of toxicology and environmental health 19800701
Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations. British medical journal 19800510
Megaloblastic anaemia due to pyridoxine deficiency associated with prolonged ingestion of an oestrogen-containing oral contraceptive. British medical journal 19761023
Intracranial venous thrombosis complicating oral contraception: treatment by anticoagulant drugs. British medical journal 19730616
Psychosis associated with the use of oral contraceptive agents. Southern medical journal 19690201

Related Products

© 2019 Angene International Limited. All rights Reserved.